Cure Rare Disease Inc
EIN: 822473513 · Woodbridge, CT · NTEE: G12
Source and Resolution Links
Finish the Investigation Outside Our Dataset
When the answer lives with the IRS, ProPublica, Candid, Charity Navigator, or the nonprofit itself, NonprofitSpending links out instead of trapping the user on a partial answer.
IRS tax-exempt lookup
Verify exemption status and deductibility directly with the IRS.
ProPublica 990 source
Open the raw filing record and filing PDFs outside NonprofitSpending.
Candid profile search
Look for GuideStar/Candid profile details, programs, leadership, and seals.
Charity Navigator search
Check whether another evaluator has ratings or impact context.
Workflow Engine
Queries We Should Resolve, Not Just Answer
Search Console demand points to task completion. Each workflow can run calculations, source checks, external lookups, comparisons, and report/export capture around this nonprofit.
Verify tax status Runnable
Triggered by: 501(c)(3), tax deductible, EIN
IRS status check plus source links
Find source filings Runnable
Triggered by: 990 PDF, annual report, filing record
6 stored filing years plus ProPublica source
Crunch money signals Runnable
Triggered by: program expense ratio, CEO salary, revenue, grants
Spending and compensation calculation
Compare alternatives Runnable
Triggered by: best charities, similar nonprofits, compare
4 peer options surfaced
Resolve leadership and board Runnable
Triggered by: executive team, trustees, officer pay
Use 990 compensation disclosures and external profile links.
| Metric | Value |
|---|---|
| Total Revenue | $5.2M |
| Total Expenses | $2.0M |
| Net Assets | $1.0M |
Search Intent Cockpit
Cure Rare Disease Inc Form 990, Revenue, CEO Pay, and IRS Filing Signals
Cure Rare Disease Inc is surfaced here as a decision-ready nonprofit financial profile, not just a charity listing. The page consolidates IRS Form 990 revenue, expenses, assets, tax-exempt classification, executive compensation, mission score, red flags, and year-by-year filing history so donors, researchers, journalists, and grant teams can answer the common search questions around Cure Rare Disease Inc in one place.
Form 990 Filing Summary
6 filing years are available, with latest revenue of $2.3M and expenses of $2.0M.
Revenue and Expenses
Cure Rare Disease Inc reported $2.3M in revenue and $2.0M in expenses, a surplus of $343K.
Executive Compensation
Officer, director, trustee, and key employee pay is reviewed from IRS 990 compensation disclosures when present.
Charity Score and Red Flags
Mission score and red-flag review are shown when AI enrichment is available.
Is Cure Rare Disease Inc Legit?
Insufficient Data
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
IRS 990 Data Cockpit
Where the Money Comes From and Where It Goes
Revenue Source Mix
Revenue-source line items are not available on the stored filing yet. Future ingestion now preserves contribution, program-revenue, and investment-income fields when ProPublica provides them.
Expense Deployment
Functional expense detail is not available on the stored filing yet. Existing program percentage and future extracted expense fields will populate this panel.
Across stored filings, Cure Rare Disease Inc shows contribution history pending. Next enrichment targets: revenue-source fields, functional expense detail, IRS BMF classification, AI synthesis.
Decision Cockpit
One-Stop Donor, Research, and Peer Context Hub
| Decision Lens | Signal | What to Inspect Next |
|---|---|---|
| Legitimacy | Insufficient Data | Good filing record; no red flags identified |
| Mission spend | Pending | Unknown |
| Financial durability | Grade A | 6 stored filing years |
| Peer context | Compare with Teen Center Of Wilton Inc | Connecticut and Category G context |
Trust Check
Review legitimacy, deductibility, red flags, and filing consistency.
Open charity check →Peer Benchmark
Compare against real state and category peers.
Compare with Teen Center Of Wilton Inc →All Connecticut nonprofits
All Category G
Local and Sector Spokes
Move into this nonprofit's local market, category, and sector maps.
Woodbridge, CT nonprofitsCategory G in Connecticut
Health in Connecticut
Follow the Money
Jump into spending, compensation, rankings, and filing-year evidence.
State spending analysisState compensation analysis
Category G spending
Best Category G charities in Connecticut
Relevant rankings
Donation Decision Flow
From Trust Check to Better Alternatives
Alternative Shopping
Similar Nonprofits Donors Should Compare
Lebanon Volunteer Fire Department
Lebanon, CT · $627K revenue · Score 95/100
Compare side-by-sideWestern Connecticut Chapter National Railway Historical Societ
Norwalk, CT · $21K revenue · Score 92/100
Compare side-by-sideConnecticut Hospitality Educational Association Inc
Wethersfield, CT · $116K revenue · Score 90/100
Compare side-by-sideConnecticut Apartment Association
West Hartford, CT · $725K revenue · Score 85/100
Compare side-by-sideNext Best Actions
Keep the Investigation Moving
Research Workflow
Turn this Form 990 profile into a donor-ready report
Request a concise report for Cure Rare Disease Inc with revenue, expenses, executive compensation, red flags, peer context, and IRS source links. You can also request CSV exports or watchlist updates for future filings.
Early access request only. Reports and exports are informational and based on public IRS records, not financial or legal advice.
About Cure Rare Disease Inc
Cure Rare Disease Inc (EIN: 822473513) is a nonprofit organization based in Woodbridge, CT, classified under NTEE code G12. The organization reported total revenue of $5.2M and total assets of $6.0M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Cure Rare Disease Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Cure Rare Disease Inc is a mid-size nonprofit that has been operating for 8 years, with 6 years of IRS 990 filings on record (2018–2023). Revenue has grown at a compound annual rate of 101.8%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $2.3M |
| Total Expenses | $2.0M |
| Surplus / Deficit | +$343K |
| Total Assets | $3.3M |
| Total Liabilities | $2.3M |
| Net Assets | $1.0M |
| Operating Margin | 14.9% |
| Debt-to-Asset Ratio | 68.8% |
| Months of Reserves | 20.1 months |
Financial Health Grade: A
In 2023, Cure Rare Disease Inc reported a surplus of $343K with revenue exceeding expenses, holds 20.1 months of operating reserves (strong position), has a debt-to-asset ratio of 68.8% (high leverage).
Financial Trends
Over 6 years of filings (2018–2023), Cure Rare Disease Inc's revenue has grown at a compound annual growth rate (CAGR) of 101.8%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | -17.8% | -39.0% | +290.4% |
| 2022 | +12.5% | +40.3% | -42.9% |
| 2021 | +173.8% | +572.7% | +47.0% |
| 2020 | +161.0% | +406.4% | +233.3% |
| 2019 | +406.4% | +28.3% | +1735.1% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 2018 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Analysis Pending
AI enrichment for Cure Rare Disease Inc has not yet been completed. Basic IRS 990 data is shown below. Check back later for a full transparency report including a Mission Score, spending breakdown, executive compensation analysis, and red flags assessment.
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Cure Rare Disease Inc with a Mission Score of 0 out of 100 (Very Poor). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $343K, with revenue exceeding expenses.
- Debt-to-asset ratio: 68.8%.
Frequently Asked Questions about Cure Rare Disease Inc
Is Cure Rare Disease Inc a legitimate charity?
Cure Rare Disease Inc (EIN: 822473513) is a registered tax-exempt nonprofit based in Connecticut. It has 6 years of IRS 990 filings on record. Total revenue: $5.2M. No red flags identified. Financial health grade: A.
How does Cure Rare Disease Inc spend its money?
Cure Rare Disease Inc reported $5.2M in total revenue in IRS 990 filings. 6 years of filing data available. Revenue exceeded expenses in the most recent year. Review the full spending breakdown on NonprofitSpending.
Are donations to Cure Rare Disease Inc tax-deductible?
Cure Rare Disease Inc is registered as a tax-exempt nonprofit (EIN: 822473513). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Where is Cure Rare Disease Inc located?
Cure Rare Disease Inc is headquartered in Woodbridge, Connecticut and files with the IRS under EIN 822473513. It is classified under NTEE code G12.
How many years of IRS 990 filings does Cure Rare Disease Inc have?
Cure Rare Disease Inc has 6 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $5.2M in total revenue.
Filing History
IRS 990 filing history for Cure Rare Disease Inc showing financial trends over 6 years of public records:
Over 6 years of IRS 990 filings (2018–2023), Cure Rare Disease Inc's revenue has grown by 3248.8%, moving from $69K to $2.3M. Total assets increased by 19947.5% over the same period, from $16K to $3.3M. Total functional expenses rose by 3638.8%, from $52K to $2.0M. In its most recent filing year (2023), Cure Rare Disease Inc reported a surplus of $343K, with revenue exceeding expenses. The organization holds $2.3M in liabilities against $3.3M in assets (debt-to-asset ratio: 68.8%), resulting in net assets of $1.0M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $2.3M | $2.0M | $3.3M | $2.3M | — | — |
| 2022 | $2.8M | $3.2M | $840K | $213K | — | View 990 |
| 2021 | $2.5M | $2.3M | $1.5M | $310K | — | — |
| 2020 | $908K | $340K | $1.0M | $135K | — | — |
| 2019 | $348K | $67K | $300K | $3K | — | View 990 |
| 2018 | $69K | $52K | $16K | $0 | — | — |
Year-by-Year Financial Summary
- 2023: Revenue of $2.3M, expenses of $2.0M, and assets of $3.3M (revenue -17.8% year-over-year).
- 2022: Revenue of $2.8M, expenses of $3.2M, and assets of $840K (revenue +12.5% year-over-year).
- 2021: Revenue of $2.5M, expenses of $2.3M, and assets of $1.5M (revenue +173.8% year-over-year).
- 2020: Revenue of $908K, expenses of $340K, and assets of $1.0M (revenue +161.0% year-over-year).
- 2019: Revenue of $348K, expenses of $67K, and assets of $300K (revenue +406.4% year-over-year).
- 2018: Revenue of $69K, expenses of $52K, and assets of $16K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Cure Rare Disease Inc:
Data Sources and Methodology
This transparency report for Cure Rare Disease Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.